2-[4-(2,4-difluorophenoxy)piperidin-1-yl]-5-methyl-3-[[(3R)-oxolan-3-yl]amino]pyrido[2,3-b]pyrazin-6-one
C23H25F2N5O3 — CID 177311912
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-(2,4-difluorophenoxy)piperidin-1-yl]-5-methyl-3-[[(3R)-oxolan-3-yl]amino]pyrido[2,3-b]pyrazin-6-one
2-[4-(2,4-difluorophenoxy)piperidin-1-yl]-5-methyl-3-[[(3R)-oxolan-3-yl]amino]pyrido[2,3-b]pyrazin-6-one (PubChem CID 177311912) has the molecular formula C23H25F2N5O3 and a molecular weight of 457.48 g/mol. Its IUPAC name is 2-[4-(2,4-difluorophenoxy)piperidin-1-yl]-5-methyl-3-[[(3R)-oxolan-3-yl]amino]pyrido[2,3-b]pyrazin-6-one.
Molecular Properties
| Compound Name | 2-[4-(2,4-difluorophenoxy)piperidin-1-yl]-5-methyl-3-[[(3R)-oxolan-3-yl]amino]pyrido[2,3-b]pyrazin-6-one |
|---|---|
| PubChem CID | 177311912 |
| Molecular Formula | C23H25F2N5O3 |
| Molecular Weight | 457.48 g/mol |
| Exact Mass | 457.19 |
| IUPAC Name | 2-[4-(2,4-difluorophenoxy)piperidin-1-yl]-5-methyl-3-[[(3R)-oxolan-3-yl]amino]pyrido[2,3-b]pyrazin-6-one |
| SMILES | Cn1c(=O)ccc2nc(N3CCC(Oc4ccc(F)cc4F)CC3)c(N[C@@H]3CCOC3)nc21 |
| InChI | InChI=1S/C23H25F2N5O3/c1-29-20(31)5-3-18-22(29)28-21(26-15-8-11-32-13-15)23(27-18)30-9-6-16(7-10-30)33-19-4-2-14(24)12-17(19)25/h2-5,12,15-16H,6-11,13H2,1H3,(H,26,28)/t15-/m1/s1 |
| InChIKey | CQUAGMAGMFXUHL-OAHLLOKOSA-N |
| XLogP | 2.86 |
| TPSA | 81.51 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 457.48 |
| LogP ≤ 5 | 2.86 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177311912 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.